Sign In

John Lee

Chief Medical Officer at PhaseBio Pharmaceuticals, Inc.

John Lee, MD, PhD, is a highly experienced medical professional who served as the Chief Medical Officer at PhaseBio Pharmaceuticals, Inc. from April 2016 to October 2023.25 In this role, he was responsible for prioritizing and accelerating the development of the company's drug candidates, as well as providing strategic leadership to scientific, clinical, and business teams.5

Dr. Lee's educational background includes:

  • MD and PhD in Medicine and Biochemistry
  • BA in Biological Sciences from Harvard University1

Prior to his position at PhaseBio, Dr. Lee held several notable roles:

  • VP, Global Head, Cardiovascular Center of Excellence at Quintiles (January 2015 - April 2016)5
  • Executive Director & Head-Cardiovascular at Bristol Myers Squibb Co.2
  • Medical Director at Merck & Co., Inc.2

Currently, as of July 2023, Dr. Lee has taken on the role of Chief Medical Officer at Nuevocor, a biotechnology company focused on developing innovative medicines for cardiomyopathies.345

Throughout his career, Dr. Lee has accumulated over 15 years of expertise in clinical development and regulatory affairs, with a particular focus on cardiovascular medicine and drug development.13 His experience spans across various phases of drug development, from Phase I to Phase III.3

Dr. Lee's LinkedIn profile can be found under the username john-lee-40359417.5

Related Questions

What are John Lee's key achievements at PhaseBio Pharmaceuticals?
How did John Lee's role at PhaseBio Pharmaceuticals evolve over time?
What specific drug candidates has John Lee prioritized and accelerated at PhaseBio?
What was John Lee's impact on the healthcare system in the Cayman Islands?
How did John Lee's career path influence his role at PhaseBio Pharmaceuticals?
John Lee
John Lee, photo 1
John Lee, photo 2
Add to my network

Location

Greater Philadelphia